Targeting lactate metabolism for cancer therapeutics.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Clinical Investigation

• Publication date

  2013-09-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI69741PMID 23999443PMCID PMC3754272
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway

  2013cited by this paper
• Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets.

  2013cited by this paper
• Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways.

  2012cited by this paper
• Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target

  2012cited by this paper
• Targeting the Lactate Transporter MCT1 in Endothelial Cells Inhibits Lactate-Induced HIF-1 Activation and Tumor Angiogenesis

  2012cited by this paper
• The monocarboxylate transporter family—Role and regulation

  2012cited by this paper
• Regulation of monocarboxylate transporter MCT1 expression by p53 mediates inward and outward lactate fluxes in tumors.

  2012cited by this paper
• Lactate Activates HIF-1 in Oxidative but Not in Warburg-Phenotype Human Tumor Cells

  2012cited by this paper
• Mouse Genetics Suggests Cell-Context Dependency for Myc-Regulated Metabolic Enzymes during Tumorigenesis

  2012cited by this paper
• Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c‐Jun activation

  2012cited by this paper
• Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay.

  2012cited by this paper
• Mitochondrial metabolism in cancer metastasis

  2012cited by this paper
• The monocarboxylate transporter family—Structure and functional characterization

  2012cited by this paper
• Galloflavin (CAS 568‐80‐9): A Novel Inhibitor of Lactate Dehydrogenase

  2012influential reference
• Lactate-induced IL-8 pathway in endothelial cells--letter.

  2012cited by this paper
• Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs)

  2012cited by this paper
• Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.

  2012cited by this paper
• Lactate Dehydrogenase B Is Required for the Growth of KRAS-Dependent Lung Adenocarcinomas

  2012cited by this paper
• CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors

  2011cited by this paper
• Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer

  2011cited by this paper
• Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells

  2011cited by this paper
• Evidence for a stromal-epithelial “lactate shuttle” in human tumors

  2011influential reference
• Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis.

  2011cited by this paper
• miR-29a and miR-29b Contribute to Pancreatic β-Cell-Specific Silencing of Monocarboxylate Transporter 1 (Mct1)

  2011cited by this paper
• A Phase II Study of AT-101 (Gossypol) in Chemotherapy-Sensitive Recurrent Extensive-Stage Small Cell Lung Cancer

  2011cited by this paper
• Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells.

  2011cited by this paper
• Metabolic targeting of lactate efflux by malignant glioma inhibits invasiveness and induces necrosis: an in vivo study.

  2011cited by this paper
• Inhibition of tumor lactate oxidation: consequences for the tumor microenvironment.

  2011cited by this paper
• IL-23-dependent and -independent enhancement pathways of IL-17A production by lactic acid.

  2011cited by this paper
• The reverse Warburg Effect: Glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts

  2010cited by this paper
• Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer

  2010cited by this paper
• Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution

  2010cited by this paper
• Derepression of Polycomb targets during pancreatic organogenesis allows insulin-producing beta-cells to adopt a neural gene activity program.

  2010cited by this paper
• Hypoxia stimulates lactate release and modulates monocarboxylate transporter (MCT1, MCT2, and MCT4) expression in human adipocytes

  2010cited by this paper
• Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression

  2010influential reference
• HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer

  2010cited by this paper
• Understanding the "lethal" drivers of tumor-stroma co-evolution

  2010cited by this paper
• Monocarboxylate transporter 1 is up‐regulated in basal‐like breast carcinoma

  2010cited by this paper
• Phase I/II Study of AT-101 with Topotecan in Relapsed and Refractory Small Cell Lung Cancer

  2010cited by this paper
• The inhibition of monocarboxylate transporter 2 (MCT2) by AR-C155858 is modulated by the associated ancillary protein

  2010cited by this paper
• Faculty Opinions recommendation of c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.

  2009cited by this paper
• Lactic Acid and Acidification Inhibit TNF Secretion and Glycolysis of Human Monocytes

  2009cited by this paper
• Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

  2009cited by this paper
• CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models

  2009cited by this paper
• AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7–10

  2009cited by this paper
• An Open-Label, Multicenter, Phase I/II Study of Single-Agent AT-101 in Men with Castrate-Resistant Prostate Cancer

  2009cited by this paper
• LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer

  2009cited by this paper
• c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism

  2009cited by this paper
• The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma

  2009cited by this paper
• Lactate Dehydrogenase 5 Expression in Squamous Cell Head and Neck Cancer Relates to Prognosis following Radical or Postoperative Radiotherapy

  2009cited by this paper
• Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3.

  2009cited by this paper
• Structural and Biochemical Studies of TIGAR (TP53-induced Glycolysis and Apoptosis Regulator)*

  2009influential reference
• Tumor-Secreted Lactic Acid Promotes IL-23/IL-17 Proinflammatory Pathway1

  2008cited by this paper
• Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction

  2008cited by this paper
• Increasing Expression of Monocarboxylate Transporters 1 and 4 Along Progression to Invasive Cervical Carcinoma

  2008cited by this paper
• Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas

  2008cited by this paper
• Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice.

  2008influential reference
• Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism.

  2008cited by this paper
• The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

  2008cited by this paper
• Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

  2007cited by this paper
• Inhibitory effect of tumor cell-derived lactic acid on human T cells.

  2007cited by this paper
• Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231.

  2007cited by this paper
• Activity‐dependent regulation of energy metabolism by astrocytes: An update

  2007influential reference
• CD147 immunoglobulin superfamily receptor function and role in pathology.

  2007cited by this paper
• Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1

  2007cited by this paper
• Lactate sensitive transcription factor network in L6 cells: activation of MCT1 and mitochondrial biogenesis

  2007influential reference
• TIGAR, a p53-inducible regulator of glycolysis and apoptosis.

  2006cited by this paper
• Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance.

  2006cited by this paper
• RADIOTHERAPY: AN IN VITRO STUDY

  2006cited by this paper
• The Plasma Membrane Lactate Transporter MCT4, but Not MCT1, Is Up-regulated by Hypoxia through a HIF-1α-dependent Mechanism*

  2006cited by this paper
• Tumor-derived lactic acid modulates dendritic cell activation and antigen expression.

  2006cited by this paper
• Inhibitory effects of statins on human monocarboxylate transporter 4.

  2006cited by this paper
• Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer

  2006cited by this paper
• The H+-Linked Monocarboxylate Transporter (MCT1/SLC16A1): A Potential Therapeutic Target for High-Risk Neuroblastoma

  2006cited by this paper
• HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia.

  2006cited by this paper
• Monocarboxylate transporter MCT1 is a target for immunosuppression

  2005cited by this paper
• Reversible Inactivation of HIF-1 Prolyl Hydroxylases Allows Cell Metabolism to Control Basal HIF-1*

  2005cited by this paper
• Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer

  2005cited by this paper
• Basigin (CD147) Is the Target for Organomercurial Inhibition of Monocarboxylate Transporter Isoforms 1 and 4

  2005influential reference
• Evaluation of Myc E-Box Phylogenetic Footprints in Glycolytic Genes by Chromatin Immunoprecipitation Assays

  2004cited by this paper
• Silencing of Monocarboxylate Transporters via Small Interfering Ribonucleic Acid Inhibits Glycolysis and Induces Cell Death in Malignant Glioma: An in Vitro Study

  2004cited by this paper
• Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis

  2003cited by this paper
• Hypoxic regulation of the 6‐phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatase gene family (PFKFB‐1–4) expression in vivo

  2003influential reference
• Reduced Expression of GNA11 and Silencing of MCT1 in Human Breast Cancers

  2003cited by this paper
• Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2–p12.1

  2003cited by this paper
• Promoter hypermethylation in cancer silences LDHB, eliminating lactate dehydrogenase isoenzymes 1-4.

  2003cited by this paper
• Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis*

  2002cited by this paper
• Hypoxia-inducible Factor-1-mediated Expression of the 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) Gene

  2002cited by this paper
• Selective active site inhibitors of human lactate dehydrogenases A4, B4, and C4.

  2001influential reference
• The transcriptional program of a human B cell line in response to Myc.

  2001cited by this paper
• Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase.

  2001cited by this paper
• The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells.

  2000cited by this paper
• CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression

  2000cited by this paper
• HIF-1: mediator of physiological and pathophysiological responses to hypoxia.

  2000cited by this paper
• Gossypol: prototype of inhibitors targeted to dinucleotide folds.

  2000cited by this paper
• Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc*

  2000cited by this paper
• Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion.

  2000cited by this paper
• Selective inhibitors of human lactate dehydrogenases and lactate dehydrogenase from the malarial parasite Plasmodium falciparum.

  1998cited by this paper
• Characterization of the monocarboxylate transporter 1 expressed in Xenopus laevis oocytes by changes in cytosolic pH.

  1998cited by this paper
• c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.

  1997cited by this paper

• The moonlighting functions of glycolytic enzymes in tumorigenesis

  2026cites this paper
• Impact of Hypoxia-inducible factor 1 in the oncogenic progression of Kaposi's sarcoma-associated herpes virus.

  2026cites this paper
• SLC2A3-Mediated Lactate Metabolism Promotes Lung Cancer Bone Metastasis by Modulating P53 Lactylation and Immune Evasion.

  2026cites this paper
• YBX1-LDHB axis orchestrates pyruvate production from lactate to promote ICC initiation and development.

  2026cites this paper
• Metabolic reprogramming in cancer: signaling pathways and therapeutic targets.

  2026cites this paper
• Multi-Omics Characterization of Lactate-Associated Molecular Subtypes in Lung Cancer Suggests a Role for DKK1 in Lactate-Linked Migration, Invasion, and Lactylation Programs

  2026cites this paper
• Glycolysis enzymes and cellular lactylation in tumour.

  2026cites this paper
• Intersection of Precision Nutrition and Bladder Cancer: A Narrative State-of-the-Art Review of Potential Applications and Challenges

  2026cites this paper
• Lactate: elucidating its indispensable role in human health

  2026cites this paper
• Lactic Acid in Tumour Biology

  2026cites this paper
• Lactate metabolism and protein lactylation in colorectal cancer: from metabolic reprogramming to epigenetic regulation

  2026cites this paper
• Utilizing the Lactate Dehydrogenase-to-Albumin Ratio for Survival Prediction in Patients with Neuroblastoma.

  2026cites this paper
• Lactylation in cancer: molecular mechanisms and advances in clinical study

  2026cites this paper
• Metabolic Radiosensitization by Targeting Lactate Metabolism with Microfluidic Liposomal Nanocarriers

  2026cites this paper
• Lactate-lactylation in tumor angiogenesis and progression: mechanisms, biomarker potential, and therapeutic implications

  2026cites this paper
• Adipose Tissue and Renal Carcinoma: A Protumor Metabolic and Endocrine Alliance

  2026cites this paper
• Targeting glycolytic enzymes to combat cancer metastasis: Strategies toward clinical translation

  2026cites this paper
• Metabolic Reprogramming and DNA Damage Response in Prostate Cancer: Implication for treatment

  2026cites this paper
• Tumor microenvironment heterogeneity and immunotherapy resistance: multidimensional modulation strategies for precision breakthroughs

  2026cites this paper
• Targeting glycolysis in prostate cancer: Molecular mechanisms and therapeutic advances.

  2026cites this paper
• Correlation of Salivary Lactate Dehydrogenase Levels with Histopathological Grades of Oral Cancer

  2026cites this paper
• Association of oral microbiota and digestive system cancers revealed by bidirectional two sample Mendelian randomization

  2026cites this paper
• Lactylation Enhances YTHDF3 Stability to Promote Cisplatin Resistance via m6A-Dependent KDM6B Decay in Bladder Cancer.

  2026cites this paper
• In Silico and In Vitro Analysis of Ganoderic Acid A Binding to Human Monocarboxylate Transporters 1 and 4.

  2026cites this paper
• Reprogramming of Thyroid Cancer Metabolism: from Mechanism to Therapeutic Strategy

  2025cites this paper
• Revisiting concepts of mitochondrial transport and energy metabolism in health and cancer

  2025cites this paper
• Lactate and lactylation in cancer

  2025cites this paper
• Clinical and radiomics parameter prognostication in metastatic uveal melanoma patients treated with hepatic arterial infusion chemotherapy

  2025cites this paper
• AKT1 Phosphorylates FDX1 to Promote Cuproptosis Resistance in Triple‐Negative Breast Cancer

  2025cites this paper
• TOMM20 as a driver of cancer aggressiveness via oxidative phosphorylation, maintenance of a reduced state, and resistance to apoptosis

  2025cites this paper
• AARS1‐mediated AKR1B10 lactylation stabilizes an aerobic glycolysis‐positive feedback loop to drive lenvatinib resistance in hepatocellular carcinoma

  2025cites this paper
• Dual role of lactate in ferroptosis: Mechanisms, pathophysiology and therapeutic opportunities (Review)

  2025cites this paper
• Targeting Lactylation for Cancer: Mechanisms, Effects, and Therapeutic Prospects

  2025cites this paper
• Protein lactylation in cancer and other pathologies: epigenetic regulation of glycolysis and its therapeutic perspectives.

  2025cites this paper
• Lactate does not replace glucose for maintaining the viability of mouse and human glioma cells

  2025cites this paper
• Emerging Roles of Nanozyme in Tumor Metabolism Regulation: Mechanisms, Applications, and Future Directions.

  2025cites this paper
• Brain abundant membrane attached signal protein 1 regulates macrophage polarization through EGFR/PI3K/AKT signaling in renal cell carcinoma.

  2025cites this paper
• Comparison of the effects of rapamycin and AZD8055 on colon cancer cells through UPLC-MS/MS-based metabolomics.

  2025cites this paper
• Metabolic reprogramming in bone metastasis of human cancers

  2025cites this paper
• Carcinogenesis: An Alternative Hypothesis Comparing Mutagenic Versus Metabolic Models

  2025cites this paper
• Loss of the Y chromosome in bladder cancer drives metabolic reprogramming

  2025cites this paper
• Integrating single-cell RNA sequencing and spatial transcriptomics to reveal the Glycolysis-related gene GPRC5A as a potential biomarker for gastric cancer by machine learning.

  2025cites this paper
• Lactate Metabolism: The String-Puller for the Development of Pancreatic Cancer

  2025cites this paper
• FAM111B Suppression Enhances Sensitivity to Gemcitabine in Pancreatic Cancer Through Intracellular pH Regulation

  2025cites this paper
• Mechanism-based targeting of lactate dehydrogenase tetramerization by naturally derived compounds: A survey of molecular docking, molecular dynamics, and QSAR analysis

  2025cites this paper
• Insights into recent findings and therapeutic potential of nonhistone lactylation in cancer

  2025cites this paper
• Autophagy induced by metabolic processes leads to solid tumor cell metastatic dormancy and recurrence

  2025cites this paper
• Cryo-EM structure of the human monocarboxylate transporter 10.

  2025cites this paper
• Bone Metastatic Progression of Prostate Cancer is Regulated by TRIM28-LDHA Mediated Metabolism.

  2025cites this paper
• Lactate and lactylation: molecular insights into histone and non-histone lactylation in tumor progression, tumor immune microenvironment, and therapeutic strategies

  2025cites this paper
• Mitochondrial Dysfunction Rewires Macrophage Metabolism, Driving Pro-inflammatory Priming and Immune System Remodeling

  2025cites this paper
• Constructing a sixteen lactate-related gene risk signature for LUAD to predict the prognosis and TME by machine learning

  2025cites this paper
• Distinct Clinical and Biological Features of Diffusely Metastatic Versus Bulky Localized Lung Cancer: Real-World Outcomes from a University Cancer Center in Germany

  2025cites this paper
• Targeting lactic acidosis in the tumor microenvironment: Enhancing TACE efficacy in hepatocellular carcinoma

  2025cites this paper
• Research landscape of glioma and inflammation over the past two decades

  2025cites this paper
• Ubiquinol-mediated suppression of mitochondria-associated ferroptosis is a targetable function of lactate dehydrogenase B in cancer

  2025cites this paper
• SLC16A3 as a novel therapeutic target for overcoming radioresistance and chemoresistance in lung cancer.

  2025cites this paper
• A Multifunctional Nanoplatform Based on Lactate Depletion and Hydrogen Peroxide Accumulation for MRI-Guided Tumor Therapy.

  2025cites this paper
• Metabolic Interactions in the Tumor Microenvironment of Classical Hodgkin Lymphoma: Implications for Targeted Therapy

  2025cites this paper
• Regulatory role and therapeutic prospect of lactate modification in cancer

  2025cites this paper
• H4K79 and H4K91 histone lactylation, newly identified lactylation sites enriched in breast cancer

  2025cites this paper
• Design and screening of novel molecular compounds targeting lactate dehydrogenase of Babesia microti

  2025cites this paper
• DIO3 depletion attenuates ovarian cancer growth via reduced glycolysis and alterations in glutamine metabolism

  2025cites this paper
• Clinical application prospects of traditional Chinese medicine as adjuvant therapy for metabolic reprogramming in colorectal cancer

  2025cites this paper
• Development and validation of a Hypoxia and Lactate Metabolism Prognostic Score (HLMPS) for breast cancer using machine learning

  2025cites this paper
• A CD147-targeted small-molecule inhibitor potentiates gemcitabine efficacy by triggering ferroptosis in pancreatic ductal adenocarcinoma

  2025cites this paper
• Research advances of lactylation modification in breast cancer

  2025cites this paper
• Hypoxia- and lactate metabolism-associated prognostic and therapeutic signature in pancreatic cancer

  2025cites this paper
• Carboxylic acid metabolism in cancer: Mechanisms, microenvironment interactions, and therapeutic opportunities.

  2025cites this paper
• KRAS mutation increases histone H3 lysine 9 lactylation (H3K9la) to promote colorectal cancer progression by facilitating cholesterol transporter GRAMD1A expression

  2025cites this paper
• Oxamate Nanoparticles for Enhanced Tumor Immunotherapy through Blocking Glycolysis Metabolism and Inducing Pyroptosis.

  2025cites this paper
• Synthesis of Bis-Pyrimidothiazine and Bis-Pyrimidothiadiazinone Derivatives as VEGFR2/KDR Inhibitors via Michael and Mannich Reactions

  2025cites this paper
• Lactate-induced lactylation: from basic research to clinical perspectives

  2025cites this paper
• Lactate cannot replace glucose for maintaining the viability of mouse and human glioma cells

  2025cites this paper
• Prognostic significance of PD-L1 and CD45RO+ cells in glioblastoma: The modulating role of MMR status.

  2025cites this paper
• Free Methylglyoxal and Lactate Produced and Released by Cultured Cancer and Non-Cancer Cells: Implications for Tumor Growth and Development

  2025cites this paper
• Lactate in ferroptosis regulation: a new perspective on tumor progression and therapy.

  2025cites this paper
• Roles of MARCKSL1, MCM6, RFC4, and PLAU genes in esophageal cancer and their association with radiotherapy response

  2025cites this paper
• The Role of Lactate in Ischemic Stroke: As an Energy Source and Signaling Molecule.

  2025cites this paper
• Prognostic value of the lactate dehydrogenase to albumin ratio in cancer patients

  2025cites this paper
• Metabolic regulation of key developmental events during mammalian embryogenesis

  2025cites this paper
• Monocarboxylate Transporter‐1 Is Dispensable for Hepatocellular Carcinoma Development

  2025cites this paper
• FOXK1-induced upregulation of NXPH4 predicts poor prognosis and promotes hepatocellular carcinoma progression via PI3K/Akt pathway.

  2025cites this paper
• Exploring the interplay between LDHA and ABCC1 in breast cancer using computational approach

  2025cites this paper
• Tumor-associated Schwann cell remodeling under metabolic stress via lactate sensing orchestrates pancreatic ductal adenocarcinoma development.

  2025cites this paper
• Lactylation in cancer biology: Unlocking new avenues for research and therapy

  2025cites this paper
• Systematic and comprehensive insights into HIF-1 stabilization under normoxic conditions: implications for cellular adaptation and therapeutic strategies in cancer

  2025cites this paper
• Developments in the study of the role of lactate metabolism in the genesis and progression of thyroid cancer

  2025cites this paper
• Multi-omics signature of healthy versus unhealthy lifestyles reveals associations with diseases

  2025cites this paper
• Glucose metabolic dysregulation and oxidative stress in cholangiocarcinoma: molecular mechanisms, oncogenic drivers, and novel therapeutic targets

  2025cites this paper
• Lactate Metabolic Checkpoint in Immuno-Oncology: mechanisms and therapeutic implications.

  2025cites this paper
• Lactate and lactylation in tumor immunity

  2025cites this paper
• From metabolic reprogramming to epigenetic modification: association network and targeted treatment strategy between histone lactylation and tumor progression

  2025cites this paper
• Dysregulation of PKM2 promotes inflammatory response in allergic rhinitis

  2025cites this paper
• Deciphering the dual role of autophagy in gastric cancer and gastroesophageal junction cancer: from tumor suppression to cancer progression

  2025cites this paper
• Mechanism analysis and targeted therapy of IDH gene mutation in glioma.

  2025cites this paper
• Machine Learning-based Lactate-Related Genes Signature Predicts Clinical Outcomes and Unveils Novel Therapeutic Targets in Esophageal Squamous Cell Carcinoma.

  2025cites this paper
• The impact of solute carrier proteins on disrupting substance regulation in metabolic disorders: insights and clinical applications

  2025cites this paper
• Lactylation: From Molecular Insights to Disease Relevance

  2025cites this paper
• Development and experimental verification of a prognosis model for hypoxia- and lactate metabolism-associated genes in HNSCC

  2025cites this paper